Steady state expression of cell-cycle regulatory genes in prostate carcinoma cell lines

被引:5
|
作者
McGarvey, TW [1 ]
Malkowicz, SB [1 ]
机构
[1] Hosp Univ Penn, Dept Surg, Div Urol, Philadelphia, PA 19104 USA
来源
UROLOGIC ONCOLOGY | 2000年 / 5卷 / 02期
关键词
cell cycle; Cdk inhibitors; prostate carcinoma; transforming growth factor-beta (TGF-beta);
D O I
10.1016/S1078-1439(99)00003-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The transforming growth factor-beta (TGF-beta) signal transduction system has been reported to play a role in prostate tumorigenesis and the regulation of cell cycle-related gene expression including the cyclins, cyclin dependent kinases (Cdks), and Cdk inhibitors. The objective of this investigation was to examine the expression of TGF-beta receptors I and II and five cell cycle-related genes-Cdk-4, p15, p21((WAF1/CIP1)) p27, and cyclin E-in three prostate carcinoma cell lines and normal prostate by quantitative reverse transcriptase (RT)/polymerase chain re action (PCR). The expression of the TGF-beta receptor II was reduced by 5.5- and 2.2-fold in the LNCaP and DU145 cells, respectively, compared with normal prostate tissue. A similar decrease was observed for the TGF-beta receptor I transcript in the LNCaP cells. In addition, 20-fold less of the TGF-beta inducible p15(inkb) transcript was produced by the LNCaP and DU145 cell Lines compared with the PC-3 cell line. The p21((WAF1/CIP1)) transcript, although present, was only 6% of normal in the DU145 and PC-3 cell lines. Furthermore, the steady state levels of p21((WAF1/CIP1)), mRNA significantly increased within 15 minutes after the addition of exogenous TGF-beta to PC-3 cells. Likewise. addition of TGF-beta antibodies to the PC-3 cells significantly reduced p21((WAF1/CIP1)) transcript levels to less than 2% of normal. This suggests that p21((WAF1/CIP1)) expression in PC-3 cells is related not only to p53 induction but may function through alternative pathways including TGF-beta. We conclude that the expression of specific cell cycle-related genes may be entirely or partially regulated by alterations in TGF-beta pathway and may play a role in prostate carcinoma development. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [21] CELL-CYCLE GENES AS POTENTIAL ONCOGENES
    BASERGA, R
    KACZMAREK, L
    CALABRETTA, B
    FERRARI, S
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1986, 367 (04): : 259 - 259
  • [22] CELL-CYCLE CONTROL GENES IN YEAST
    NURSE, P
    TRENDS IN GENETICS, 1985, 1 (02) : 51 - 55
  • [23] CELL-CYCLE GENES OF THE FISSION YEAST
    LEE, MG
    NURSE, P
    SCIENCE PROGRESS, 1987, 71 (281) : 1 - 14
  • [24] CELL-CYCLE - IN AND OUT OF THE CELL-CYCLE
    FORSBURG, SL
    CURRENT BIOLOGY, 1994, 4 (09) : 828 - 830
  • [25] Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms
    Kebebew, E
    Peng, M
    Reiff, E
    Duh, QY
    Clark, OH
    McMillan, A
    WORLD JOURNAL OF SURGERY, 2006, 30 (05) : 767 - 774
  • [26] Aberrant cell cycle and expression profiles of cell cycle regulatory genes in myelodysplastic syndrome.
    Shao, ZH
    Shi, J
    Liu, H
    Sun, J
    Jia, HR
    Bai, J
    He, GS
    Cao, YR
    Tu, MF
    Wang, HQ
    Xing, LM
    BLOOD, 2005, 106 (11) : 304B - 304B
  • [27] Diagnostic and Prognostic Value of Cell-cycle Regulatory Genes in Malignant Thyroid Neoplasms
    Electron Kebebew
    Miao Peng
    Emily Reiff
    Quan-Yang Duh
    Orlo H. Clark
    Alex McMillan
    World Journal of Surgery, 2006, 30 : 767 - 774
  • [28] Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines
    Venkateswaran, V
    Klotz, LH
    Fleshner, NE
    CANCER RESEARCH, 2002, 62 (09) : 2540 - 2545
  • [29] Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines
    Venkateswaran, V
    Fleshner, NE
    Klotz, LH
    JOURNAL OF UROLOGY, 2002, 167 (04): : 57 - 57
  • [30] Expression of Apoptosis and Cell-cycle Regulators in Rat Prostate Overexpressing Regucalcin
    Vaz, C. V.
    Marques, R.
    Maia, C. J.
    Alves, M.
    Cavaco, J. E.
    Oliveira, P. F.
    Socorro, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S42 - S42